Fetal Genetic Screening Tests
Create a requestFetal genetic screening tests are a range of non-invasive and invasive tests conducted during pregnancy to evaluate the risk of the fetus having genetic disorders such as Down syndrome, cystic fibrosis, or spina bifida. These tests provide early information that can be vital for the management of the pregnancy.
General
Fetal genetic screening tests begin with non-invasive procedures that assess the risk of the fetus having genetic abnormalities. This includes blood tests from the mother and ultrasound evaluations to measure certain markers. Invasive tests, like amniocentesis or chorionic villus sampling (CVS), may be offered if the initial tests indicate a high risk, providing a more definitive diagnosis. These advanced tests involve collecting samples from the amniotic fluid or placental tissue, thereby directly analyzing fetal DNA. The choice between non-invasive and invasive testing depends on the preliminary risk assessment and the parents' preferences regarding diagnostic accuracy versus the risk of miscarriage with invasive procedures. The primary goal of fetal genetic screening is to provide expectant parents with information about the genetic health of their fetus, allowing them to make informed decisions about their pregnancy.
Special Details
Who is it for?
Women over the age of 35, as the risk of genetic abnormalities increases with maternal age.
Couples with a family history of genetic disorders.
Couples who have had a previous pregnancy affected by a genetic condition.
Individuals of certain ethnic backgrounds that have a higher prevalence of specific genetic conditions.
Recovery Period
Non-invasive tests do not require recovery time.
Invasive tests like amniocentesis and CVS may require a few days of rest to minimize the risk of miscarriage.
The emotional impact of the results can vary, and psychological recovery may take longer.
Potential Risks and Side Effects
Non-invasive tests carry minimal risk, mostly related to emotional distress from results.
Invasive tests carry a small risk of miscarriage (less than 1% for amniocentesis and 1-2% for CVS).
False-positive and false-negative results are possible, potentially leading to unnecessary anxiety or reassurance.
Alternative Treatments
Preimplantation genetic diagnosis (PGD) with in vitro fertilization (IVF) for couples at risk of transmitting genetic disorders.
Adoption or sperm/egg donation if genetic concerns are significant and cannot be addressed through screening or treatment.
Success Rate
Most fetal genetic screening tests have a detection rate of over 90% for certain conditions like Down syndrome, with a low false-positive rate in the latest non-invasive methods.
Procedure step-by-step overivew
Initial consultation to assess risk factors and choose appropriate tests.
Blood tests and/or ultrasound for non-invasive screening.
If high risk is identified, options for invasive testing like CVS or amniocentesis are discussed.
For invasive tests, a sample of amniotic fluid or placental tissue is collected.
Genetic analysis of the collected samples is conducted in a laboratory.
Results are provided to the parents, often with genetic counseling to help interpret the findings.
Prices
Turkey
$200 - $600
Czech Republic
$250 - $700
Croatia
$300 - $750
Lithuania
$200 - $650
Poland
$250 - $700
Germany
$350 - $900
Switzerland
$500 - $1200
France
$300 - $850
United Kingdom
$400 - $1000
United States
$200 - $2000
Canada
$300 - $1000
Australia
$250 - $800
Why Do Prices Vary?
Type of test performed (non-invasive generally cost less than invasive).
The geographic location where the test is conducted.
Whether the test is covered by insurance or public health care systems.
The facility or lab where the tests are processed.
Related Blog Posts
